Intervention of non-small cell line cancer oncogenic pathways with delta-tocotrienol

<p>Non-small cell lung cancer (NSCLC) is most hostile and leading cause of cancer deaths in the United States. Clinical data has demonstrated that 30 % of NSCLC patients have increased Notch activity and 10% of NSCLC have gain-of-function mutation on Notch-1 gene. Our data demonstrated that delta-tocotrienol could inhibit NSCLC cells proliferation, invasion and induce apoptosis by down-regulation of the Notch-1 signaling pathway. Using microRNA microarray and microRNA transfection, our findings further suggest that delta-tocotrienol is a non-toxic activator of miR-34a which can inhibit NSCLC cell proliferation, induce apoptosis, and inhibit invasion. Last but not the least, We observed that delta-tocotrienol individually or in combination with cisplatin exhibited potent anticancer abilities in NSCLC cells by down-regulating oncogenic pathways such as Notch-1 and NF-ĸB pathways and up-regulating the tumor suppressor pathways such as Bcl-2, caspase-3. Decreased NF- κB activity was observed in both cell lines in combination treatment along with significantly reduced levels of angiogenic factors MMP-9, VEGF thus offering a potential starting point for the design of novel anticancer agents. Overall, our results suggest that delta-tocotrienol could be a promising approach for designing tailored novel combination therapies for the treatment of human NSCLC.</p>

Name thesis:degree_name

Ph.D.

Level thesis:degree_level

Open Access Dissertation

Discipline thesis:degree_discipline

Nutrition and Food Science

Year dc:date.available

2012

Author dc:creator

• Ji, Xiangming

Contributors dc:contributor

• Smiti Gupta

• delta-tocotrienol, lung cancer, Notch-1
• Nutrition

Repository record dc:identifier

https://digitalcommons.wayne.edu/oa_dissertations/546

OAI identifier oai:identifier

oai:digitalcommons.wayne.edu:oa_dissertations-1545